HCR vs. CABG Study

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

July 27, 2018

Study Completion Date

July 27, 2018

Conditions
Coronary Artery Disease
Interventions
PROCEDURE

Hybrid Coronary Revascularization (HCR)

Hybrid coronary revascularization (HCR) is a combination of surgery and catheter procedures to open up clogged heart arteries. HCR is the intentional combination of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI). The HCR strategy combines grafting of the left anterior descending artery (LAD) coronary artery using the left internal mammary artery (LIMA) with PCI of non-LAD coronary stenoses. Drug-eluting stents are substituted for saphenous vein grafts (SVG) for non-LAD coronary targets, and the surgical LIMA to LAD bypass is performed, ideally through a minimally invasive, limited access, sternal-sparing approach.

PROCEDURE

Coronary Artery Bypass Grafting (CABG)

Coronary artery bypass grafting (CABG) is a surgery to create a new path for blood flow to the heart. A healthy section of vein or artery from elsewhere in the patient's body will be attached to the coronary artery just above and below the area of concern, to create a way for blood to bypass the blocked part of the coronary artery.

Trial Locations (1)

30308

Emory University Hospital Midtown, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT02892474 - HCR vs. CABG Study | Biotech Hunter | Biotech Hunter